Logistics Horizon Scanner: October 2025
Logistics Horizon Scanner: October 2025 Walker Morris provides an overview of key developments in the logistics industry, noting that "tech innovation, cybersecurity, geopolitical tensions…
Saudi Railway Company, Ericsson ink 5G pact
Saudi Railway Company and Ericsson Partner on 5G Technology The Saudi Railway Company (SAR) has signed a memorandum of understanding (MoU)…
Which Non-League sides will take part in the Isuzu FA Trophy Second Round Proper? - The Non-League Football Paper
Isuzu FA Trophy Second Round Proper Draw Confirmed The draw for the Isuzu FA Trophy Second Round Proper has been confirmed, with 40 ties s…
Lululemon to sell NFL apparel in Fanatics deal
Lululemon to Sell NFL Apparel in Fanatics Deal Lululemon has entered an arrangement with the NFL and Fanatics to develop a line of fan app…
Sara Davies' DIY spooky sweet treats are perfect for this week's Halloween celebrations
Sara Davies' DIY Spooky Sweet Treats for Halloween Sara Davies' DIY spooky sweet treats are perfect for this week's Halloween celebrations…
Kymera Therapeutics, Inc.: Kymera Therapeutics Presents New Preclinical Data for KT-579, a First-in-Class, Oral IRF5 Degrader, at the American College of Rheumatology Annual Meeting
Kymera Therapeutics Presents New Preclinical Data for KT-579 Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, announ…
Here’s why Utah’s Olympic organizers are in NYC this week
Utah's Olympic Organizers in NYC Leaders of Utah's 2034 Winter Games are attending the U.S. Olympic and Paralympic Committee Team USA Medi…
Was Salt Lake City’s ‘No Kings’ protest a success? Organizers look back, and look ahead.
Assessing the "No Kings" Protest in Salt Lake City The second "No Kings" protest in Salt Lake City has concluded, and organizers are refle…
Neumora Therapeutics, Inc.: Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-898
Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study Neumora Therapeutics, Inc. has started a Phase 1 clinical study of NMR…
OPPO, Ballet Philippines to promote Filipino Artistry with new partnership
OPPO and Ballet Philippines Partnership OPPO has announced a partnership with Ballet Philippines to promote Filipino artistry, marking the…
Pacira BioSciences Notified of Abbreviated New Drug Application Filing from Qilu Pharmaceutical (Hainan) Co., Ltd. for EXPAREL
Pacira BioSciences Notified of Abbreviated New Drug Application Filing Pacira BioSciences, Inc. (Nasdaq: PCRX), a leader in non-opioid pai…